{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:20:54Z","timestamp":1795044054269,"version":"4.10.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"MH CZ - DRO","award":["UHHK, 00179906"],"award-info":[{"award-number":["UHHK, 00179906"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12894-017-0222-6","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T08:57:20Z","timestamp":1493197040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study"],"prefix":"10.1186","volume":"17","author":[{"given":"Miroslav","family":"Fajfr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Louda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Paterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Ry\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pacovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Ko\u0161ina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"\u017demli\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Bro\u010f\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"222_CR1","doi-asserted-by":"crossref","unstructured":"Frimondt-M\u00f8ller N. Chapter 73 \u2013 Fosfomycin, in Kucers\u2019 The Use of Antibiotics, 6th Edition. Lead Editor M. Lindsay Grayson. USA: CRC Press. 2010","DOI":"10.1201\/b13787-84"},{"issue":"3","key":"222_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"222_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/JCM.03484-13","volume":"52","author":"M Kaase","year":"2014","unstructured":"Kaase M, Szabados F, Anders A, Gatermann SG. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol. 2014;52(6):1893\u20137.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"222_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","volume":"34","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents. 2009;34(2):111\u201320.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"222_CR5","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1128\/AAC.02420-12","volume":"58","author":"R Mihailescu","year":"2014","unstructured":"Mihailescu R, Furustrand Tafin U, Corvec S, Oliva A, Betrisey B, Borens O, Trampuz A. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2014;58(5):2547\u201353.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"222_CR6","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1128\/AAC.00402-12","volume":"56","author":"EA Neuner","year":"2012","unstructured":"Neuner EA, Sekeres J, Hall GS, van Duin D. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother. 2012;56(11):5744\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"222_CR7","unstructured":"The European Association of Urology. Guidelines on Urological Infection, version 2015. http:\/\/uroweb.org\/guideline\/urological-infections\/?type=archive"},{"key":"222_CR8","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents\/ ."},{"key":"222_CR9","unstructured":"The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty \u2013 Third Informational Supplement. Pennsylvania 19087, USA, 2013."},{"issue":"3","key":"222_CR10","first-page":"100","volume":"18","author":"J Hrab\u00e1k","year":"2009","unstructured":"Hrab\u00e1k J, Bergerov\u00e1 T, Zemli\u010dkov\u00e1 H, Urb\u00e1\u0161kov\u00e1 P. Detection of extended-spectrum \u00df-lactamases, AmpC \u00df-lactamases, metallo-\u00df-lactamases and Klebsiella pneumoniae carbapenemases in Gram-negative rods. Zpr\u00e1vy EMI. 2009;18(3):100\u20136.","journal-title":"Zpr\u00e1vy EMI"},{"issue":"1","key":"222_CR11","doi-asserted-by":"publisher","first-page":"e86634","DOI":"10.1371\/journal.pone.0086634","volume":"9","author":"M Koningstein","year":"2014","unstructured":"Koningstein M, van der Bij AK, de Kraker MEA, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, van Hall MA ISIS-AR Study Group. Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands. PLoS ONE. 2014;9(1):e86634. doi: 10.1371\/journal.pone.0086634 .","journal-title":"PLoS ONE"},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fmicb.2014.00551","volume":"5","author":"N Cassir","year":"2014","unstructured":"Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014;5:551. doi: 10.3389\/fmicb.2014.00551 .","journal-title":"Front Microbiol"},{"issue":"2","key":"222_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0974-2727.119849","volume":"5","author":"V Gupta","year":"2013","unstructured":"Gupta V, Rani H, Singla N, Kaisha N, Chander J. Determination of Extended-Spectrum- \u03b2-Lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to Fosfomycin. J Lab Physicians. 2013;5(2):90\u20133.","journal-title":"J Lab Physicians"},{"issue":"4","key":"222_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1590\/S0036-46652014000400009","volume":"56","author":"EJ Miranda","year":"2014","unstructured":"Miranda EJ, Oliveira GS, Roque FL, Santos SR, Olmos RD, Lotufo PA. Susceptibility to antibiotics in urinary tract infections in a secondary care setting from 2005-2006 and 2010-2011, in S\u00e3o Paulo, Brazil: data from 11,943 urine cultures. Rev Inst Med Trop Sao Paulo. 2014;56(4):313\u201324.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"222_CR15","doi-asserted-by":"publisher","first-page":"e004152","DOI":"10.1136\/bmjopen-2013-004152","volume":"3","author":"L-D Qiao","year":"2013","unstructured":"Qiao L-D, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM, Zhao XK, Gao XF, Chen M, Tian Y. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open. 2013;3:e004152. doi: 10.1136\/bmjopen-2013-004152 .","journal-title":"BMJ Open"},{"issue":"10","key":"222_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajic.2014.06.013","volume":"42","author":"A Sorlozano","year":"2014","unstructured":"Sorlozano A, Jimenez-Pacheco A, de Dios Luna Del Castillo J, Sampedro A, Martinez-Brocal A, Miranda-Casas C, Navarro-Mar\u00ed JM, Guti\u00e9rrez-Fern\u00e1ndez J. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infection: a 7-year surveillance study. Am J Infect Control. 2014;42(10):1033\u20138.","journal-title":"Am J Infect Control"},{"issue":"3","key":"222_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1128\/AAC.02048-13","volume":"58","author":"LV Perdig\u00e3o-Neto","year":"2014","unstructured":"Perdig\u00e3o-Neto LV, Oliveira MS, Rizek CF, Carrilho CM, Costa SF, Levin AS. Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods. Antimicrob Agents Chemother. 2014;58(3):1763\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"222_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jmii.2010.08.012","volume":"44","author":"HY Liu","year":"2011","unstructured":"Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect. 2011;44(5):364\u20138.","journal-title":"J Microbiol Immunol Infect"},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/jac\/dkq051","volume":"65","author":"RJ Chislett","year":"2010","unstructured":"Chislett RJ, White G, Hills T, Turner DP. Fosfomycin susceptibility among extended-spectrum beta-lactamase producing Escherichia coli in Nottingham, UK. J Antimicrob Chemother. 2010;65:1076\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2490-12-33","volume":"12","author":"G Schmiemann","year":"2012","unstructured":"Schmiemann G, G\u00e1gyor I, Hummers-Pradier E, Bleidorn. Resistance profiles of urinary tract infections in general practice - an observational study. BMC Urol. 2012;12:33. doi: 10.1186\/1471-2490-12-33 .","journal-title":"BMC Urol"},{"issue":"1","key":"222_CR21","first-page":"43","volume":"26","author":"C Rodr\u00edguez-Avial","year":"2013","unstructured":"Rodr\u00edguez-Avial C, Rodr\u00edguez-Avial I, Hern\u00e1ndez E, Picazo JJ. Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011). Rev Esp Quimioter. 2013;26(1):43\u20136.","journal-title":"Rev Esp Quimioter"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-017-0222-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T21:31:50Z","timestamp":1569101510000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-017-0222-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/s12894-017-0222-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"article-number":"33"}}